Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Combination of anti-LAG-3 antibodies and anti-PD-1 antibodies to treat tumors

Combination of anti-LAG-3 antibodies and anti-PD-1 antibodies to treat tumors

US Patent 11274152 · Granted Mar 15, 2022

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Anti-CD19/anti-CD38 common light chain bispecific antibodies2025
Antibodies binding to ILT42025
Antibodies binding to ILT42025
Antibodies binding to ILT42025
Antibodies against TIM3 and uses thereof2025
Antibodies against TIM3 and uses thereof2025
Combination of TIM-4 antagonist and PD-1 antagonist and methods of use2025
Antibodies binding to VISTA at acidic pH2025
Antibodies binding to vista at acidic pH2024
CD19/CD38 multispecific antibodies2024
Antibodies against TIM3 and uses thereof2024
Antibodies against TIM3 and uses thereof2024